NCT07821138

Brief Summary

This study compares the Enhanced Recovery After Surgery (ERAS) protocol to traditional postoperative care in pediatric patients undergoing elective ileostomy reversal. The ERAS protocol uses a standardized approach to minimize surgical stress, lower complication rates, and improve recovery times. Participants are randomly assigned to either the ERAS protocol group or the traditional care group. The main goal of this study is to measure and compare the average length of post-operative hospital stay between the two groups. Additional outcomes evaluated include post-procedure pain scores, time to bladder catheter removal, duration of intravenous fluids, time to start oral feeding, and time to mobilization.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Sep 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Sep 2026Apr 2027

First Submitted

Initial submission to the registry

September 10, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 15, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

September 15, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2027

Last Updated

September 17, 2026

Status Verified

September 1, 2026

Enrollment Period

7 months

First QC Date

September 10, 2026

Last Update Submit

September 15, 2026

Conditions

Keywords

ERAS

Outcome Measures

Primary Outcomes (2)

  • Length of Postoperative Hospital stay

    total duration of hospital stay recorded in days from the completion of surgery until discharge

    From date of surgery up to 30 days

  • Length of postoperative Hospital Stay

    total duration of hospital stay recorded in days from the completion of surgery until discharge

    date of surgery up to 30 days

Study Arms (2)

Experimental: ERAS protocol

EXPERIMENTAL

Pediatric patients undergoing elective ileostomy reversal managed under the Enhanced Recovery After Surgery (ERAS) protocol, featuring early mobilization, early oral feeding, early catheter removal, and multimodal analgesia.

Other: ERAS protocol

Active comparator : Traditional care group

ACTIVE COMPARATOR

Pediatric patients undergoing elective ileostomy reversal managed under standard postoperative care routines, including traditional fasting periods, routine IV fluid management, and standard analgesia.

Other: Traditional care

Interventions

Enhanced Recovery After Surgery multimodal protocol involving early oral feeding, early catheter removal, early mobilization, and multimodal pain control Recovery after surgery

Experimental: ERAS protocol

Standard postoperative care protocol with conventional fasting, standard intravenous fluids, and routine pain management

Active comparator : Traditional care group

Eligibility Criteria

Age6 Months - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric patients undergoing elective ileostomy reversal. Patients who previously had stoma formation for conditions such as Hirschsprung disease, necrotizing enterocolitis (NEC), or anorectal malformation (ARM).
  • Written informed consent obtained from parent/guardian.

You may not qualify if:

  • Emergency ileostomy reversal surgeries. Presence of severe systemic comorbidities or severe sepsis prior to surgery. Refusal to give consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident surgeon

Study Record Dates

First Submitted

September 10, 2026

First Posted

September 15, 2026

Study Start

September 15, 2026

Primary Completion (Estimated)

April 15, 2027

Study Completion (Estimated)

April 15, 2027

Last Updated

September 17, 2026

Record last verified: 2026-09